X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (812) 812
Patent (26) 26
Book Chapter (22) 22
Publication (8) 8
Book / eBook (4) 4
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (361) 361
life sciences & biomedicine (350) 350
humans (333) 333
female (165) 165
endocrinology & metabolism (141) 141
osteoporosis (141) 141
male (123) 123
middle aged (102) 102
aged (88) 88
adult (85) 85
animals (61) 61
endocrinology (55) 55
medicine & public health (50) 50
orthopedics (50) 50
fractures (49) 49
rheumatology (48) 48
risk factors (47) 47
research (40) 40
analysis (39) 39
genotype (39) 39
bone density (37) 37
health aspects (37) 37
original (37) 37
parathyroid hormone (37) 37
mini-review (35) 35
review (35) 35
aged, 80 and over (34) 34
mutation (32) 32
surgery (32) 32
cells, cultured (31) 31
oncology (31) 31
cell biology (29) 29
original article (29) 29
medicine (28) 28
genetic aspects (27) 27
internal medicine (27) 27
italy (27) 27
polymorphism, genetic (27) 27
biochemistry & molecular biology (26) 26
bones (26) 26
vitamin d (26) 26
bone mineral density (25) 25
care and treatment (25) 25
cell line (25) 25
general & internal medicine (24) 24
hyperparathyroidism (24) 24
medicine, general & internal (24) 24
medicine, research & experimental (24) 24
research & experimental medicine (24) 24
alleles (23) 23
multiple endocrine neoplasia type 1 - genetics (23) 23
adolescent (22) 22
child (22) 22
genetics (22) 22
geriatrics & gerontology (22) 22
epidemiology (21) 21
osteoarthritis (21) 21
osteoporosis - genetics (21) 21
pharmacology & pharmacy (21) 21
research article (21) 21
treatment outcome (21) 21
bone density conservation agents - therapeutic use (20) 20
calcium (20) 20
endocrine system diseases (20) 20
human necessities (20) 20
hygiene (20) 20
medical or veterinary science (20) 20
osteoporosis - drug therapy (20) 20
preparations for medical, dental, or toilet purposes (20) 20
primary hyperparathyroidism (20) 20
cattle (19) 19
diagnosis (19) 19
genetic predisposition to disease (19) 19
genetics & heredity (19) 19
hypoparathyroidism (19) 19
multiple endocrine neoplasia type 1 (18) 18
postmenopausal women (18) 18
chemistry (17) 17
from the editor-in-chief (17) 17
life sciences (17) 17
young adult (17) 17
bone density - genetics (16) 16
child, preschool (16) 16
cohort studies (16) 16
estrogen (16) 16
medical and health sciences (16) 16
medicin och hälsovetenskap (16) 16
osteoporosis, postmenopausal - drug therapy (16) 16
tumor cells, cultured (16) 16
tumors (16) 16
abridged index medicus (15) 15
cyclic amp - metabolism (15) 15
medical research (15) 15
musculoskeletal diseases (15) 15
pedigree (15) 15
phenotype (15) 15
physiological aspects (15) 15
rats (15) 15
risk assessment (15) 15
bone and bones - metabolism (14) 14
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (857) 857
Italian (15) 15
Portuguese (7) 7
French (6) 6
Japanese (4) 4
Spanish (4) 4
German (2) 2
Chinese (1) 1
Indonesian (1) 1
Polish (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 15, pp. 1417 - 1427
Among postmenopausal women with osteoporosis and a high risk of fracture, treatment with the monoclonal antibody romosozumab for 12 months followed by... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Risk | Bone Remodeling - drug effects | Alendronate - therapeutic use | Incidence | Spinal Fractures - prevention & control | Female | Drug Therapy, Combination | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Osteoporosis, Postmenopausal - drug therapy | Bone Density Conservation Agents - pharmacology | Alendronate - adverse effects | Bone Density - drug effects | Alendronate - pharmacology | Least-Squares Analysis | Aged | Cardiovascular Diseases - chemically induced | Fractures, Bone - prevention & control | Treatment outcome | Care and treatment | Fractures | Growth | Analysis | Monoclonal antibodies | Bones | Research | Jaw | Femur | Vertebrae | Immunoglobulins | Inhibitor drugs | Osteonecrosis | SOST protein | Bisphosphonates | Hip | Post-menopause | Bone resorption | Osteoporosis | Alendronic acid | Bone growth | Bone density | Drug therapy | Osteogenesis | randomized-trial | metaanalysis | disease | postmenopausal women | strength | bone-mineral density | Klinisk medicin | vertebral fractures | sclerosteosis | Clinical Medicine | aorta | risk
Journal Article
Expert Opinion on Investigational Drugs, ISSN 1354-3784, 08/2012, Volume 21, Issue 8, pp. 1169 - 1176
Journal Article